+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Saliva Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 186 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5924965
The Artificial Saliva Market is poised for significant growth, driven by a surge in per capita spending on oral care products. According to data from the World Health Organization, oral diseases rank as the fourth-most expensive diseases to treat globally, affecting both emerging and developed economies. The growing expenditure on oral health maintenance has a direct impact on the artificial saliva market.

Key Drivers:

  • Increase in Disposable Income: The artificial saliva market, being consumer-based, is expected to witness growth with an increase in disposable income and per capita spending. As individuals allocate more resources to oral care, the demand for artificial saliva products is likely to rise steadily.
  • Dysphagia Prevention: Studies have demonstrated the effectiveness of artificial saliva products in reducing dysphagia symptoms among patients undergoing cancer treatment. With aging populations in regions like Europe, North America, and Japan, the market for dysphagia supplements presents a lucrative opportunity for the artificial saliva market.
  • Preference for Oral Gels and Liquids: Within the artificial saliva market, oral gels and oral liquids are favored due to their ease of use. These products promote compliance, as they are associated with oral hygiene, unlike tablets, which may have lower compliance rates due to their medicinal connotations. Among these, oral liquids hold greater potential as a key segment.
  • Dominance of Oral Sprays: The oral sprays segment currently commands the highest revenue share in the artificial saliva market and is expected to maintain its lead throughout the forecast period. Oral sprays are preferred for their convenience and affordability.

Challenges Ahead:

  • Availability of Alternatives: The artificial saliva market faces competition from alternative treatments for dry mouth, including herbal medicines, acupuncture, and salivary stimulants. These alternatives pose a challenge to the unencumbered growth of the artificial saliva market. Additionally, ongoing research and development efforts to develop artificial salivary glands for individuals with salivary gland damage and the emergence of saliva stimulating pens further complicate the market landscape.

Competitive Analysis:

Key Companies Profiled

  • GlaxoSmithKline plc
  • Cipla Limited
  • Mission Pharmacal Company
  • Fresenius Kabi
  • Parnell Pharmaceuticals, Inc.
  • CCMed Group
  • Entod International
  • Midatech Pharma Plc.
  • Forward Science
  • Valeant Pharmaceuticals International, Inc.
  • Biocosmetics Laboratories
  • Icpa Health Products Ltd.
  • Perrigo
  • Laboratorios Kin, S.A.

Artificial Saliva Market Segmentation

Product Type

  • Oral Spray
  • Oral Solution
  • Oral Liquid
  • Gel
  • Powder

Age Group

  • Adult
  • Paediatric

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
  • Hypermarkets and Supermarkets

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Surgical Gowns Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Surgical Gowns Market Outlook, 2018 - 2031
3.1. Global Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Disposable
3.1.1.2. Reusable
3.2. Global Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Clinics & Trauma Centers
3.2.1.3. Ambulatory Surgical Centers
3.3. Global Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Online Sales
3.3.1.2. Retail Pharmacies
3.3.1.3. Direct Sales
3.4. Global Surgical Gowns Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Surgical Gowns Market Outlook, 2018 - 2031
4.1. North America Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Disposable
4.1.1.2. Reusable
4.2. North America Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Clinics & Trauma Centers
4.2.1.3. Ambulatory Surgical Centers
4.3. North America Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Online Sales
4.3.1.2. Retail Pharmacies
4.3.1.3. Direct Sales
4.4. North America Surgical Gowns Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Surgical Gowns Market Outlook, 2018 - 2031
5.1. Europe Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Disposable
5.1.1.2. Reusable
5.2. Europe Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Clinics & Trauma Centers
5.2.1.3. Ambulatory Surgical Centers
5.3. Europe Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Online Sales
5.3.1.2. Retail Pharmacies
5.3.1.3. Direct Sales
5.4. Europe Surgical Gowns Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Surgical Gowns Market Outlook, 2018 - 2031
6.1. Asia Pacific Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Disposable
6.1.1.2. Reusable
6.2. Asia Pacific Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Clinics & Trauma Centers
6.2.1.3. Ambulatory Surgical Centers
6.3. Asia Pacific Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Online Sales
6.3.1.2. Retail Pharmacies
6.3.1.3. Direct Sales
6.4. Asia Pacific Surgical Gowns Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Surgical Gowns Market Outlook, 2018 - 2031
7.1. Latin America Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Disposable
7.1.1.2. Reusable
7.2. Latin America Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Clinics & Trauma Centers
7.2.1.3. Ambulatory Surgical Centers
7.3. Latin America Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Online Sales
7.3.1.2. Retail Pharmacies
7.3.1.3. Direct Sales
7.4. Latin America Surgical Gowns Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Surgical Gowns Market Outlook, 2018 - 2031
8.1. Middle East & Africa Surgical Gowns Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Disposable
8.1.1.2. Reusable
8.2. Middle East & Africa Surgical Gowns Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Clinics & Trauma Centers
8.2.1.3. Ambulatory Surgical Centers
8.3. Middle East & Africa Surgical Gowns Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Online Sales
8.3.1.2. Retail Pharmacies
8.3.1.3. Direct Sales
8.4. Middle East & Africa Surgical Gowns Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Surgical Gowns Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Surgical Gowns Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Surgical Gowns Market Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product Type vs Distribution Channel Heatmap
9.2. Manufacturer vs Distribution Channel Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Ahlstrom-Munksjö
9.5.1.1. Company Overview
9.5.1.2. Product Type Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Alan Medical
9.5.2.1. Company Overview
9.5.2.2. Product Type Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Cardinal Health, INC.
9.5.3.1. Company Overview
9.5.3.2. Product Type Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. FULLSTAR NON-WOVEN PRODUCTS CO. LTD.
9.5.4.1. Company Overview
9.5.4.2. Product Type Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Garmex Andrzej Jafiszow, Wojciech Kaminski sp. J.
9.5.5.1. Company Overview
9.5.5.2. Product Type Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. GrupA Medical Products
9.5.6.1. Company Overview
9.5.6.2. Product Type Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Halyard Health, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Type Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Hogy Medical Co. Ltd.
9.5.8.1. Company Overview
9.5.8.2. Product Type Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Johnson & Johnson
9.5.9.1. Company Overview
9.5.9.2. Product Type Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Lohmann & Rauscher GmbH & Co. KG
9.5.10.1. Company Overview
9.5.10.2. Product Type Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Medline Industries, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Type Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Molnlycke Health Care
9.5.12.1. Company Overview
9.5.12.2. Product Type Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. NUREL MEDIKAL SANAYI VE TICARET ANONIM SIRKETI
9.5.13.1. Company Overview
9.5.13.2. Product Type Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Paul Hartmann AG
9.5.14.1. Company Overview
9.5.14.2. Product Type Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. PRIMED Medical Products, Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Type Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Priontex (PTY) LTD
9.5.16.1. Company Overview
9.5.16.2. Product Type Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. TIDI Products LLC
9.5.17.1. Company Overview
9.5.17.2. Product Type Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Vygon S.A.
9.5.18.1. Company Overview
9.5.18.2. Product Type Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
9.5.19. 3M Company
9.5.19.1. Company Overview
9.5.19.2. Product Type Portfolio
9.5.19.3. Financial Overview
9.5.19.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • GlaxoSmithKline plc
  • Cipla Limited
  • Mission Pharmacal Company
  • Fresenius Kabi
  • Parnell Pharmaceuticals, Inc.
  • CCMed Group
  • Entod International
  • Midatech Pharma Plc.
  • Forward Science
  • Valeant Pharmaceuticals International, Inc.
  • Biocosmetics Laboratories
  • Icpa Health Products LTD.
  • Perrigo
  • Laboratorios Kin, S.A.

Methodology

Loading
LOADING...